Antibiotics in treating oral-facial infections of odontogenic origin: an update.
Wynn
R L
RL
Department of Oral-Craniofacial Biological Sciences, Dental School, University of Maryland at Baltimore, USA.
Bergman
S A
SA
Meiller
T F
TF
Crossley
H L
HL
D000328:Adult; D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000145:classification / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use; D001420:Bacteria, Aerobic / Q000145:classification; D001421:Bacteria, Anaerobic / Q000145:classification; D001424:Bacterial Infections / Q000188:drug therapy*; D002511:Cephalosporins / Q000145:classification / Q000627:therapeutic use; D002648:Child; D017291:Clarithromycin / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D024881:Drug Resistance, Bacterial; D004917:Erythromycin / Q000627:therapeutic use; D005491:Focal Infection, Dental / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D009059:Mouth Diseases / Q000382:microbiology; D010404:Penicillin V / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D014076:Tooth Diseases / Q000382:microbiology
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D002981:Clindamycin; D004917:Erythromycin; D000658:Amoxicillin; D017963:Azithromycin; D017291:Clarithromycin; D010404:Penicillin V